Tammy Furlong's most recent trade in Elevation Oncology Inc was a trade of 275,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 23, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Jul 2025 | 275,000 | 0 | - | - | Stock Option (Right to Buy) | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Jul 2025 | 225,000 | 0 | - | - | Stock Option (Right to Buy) | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Jul 2025 | 79,327 | 0 | - | - | Stock Option (Right to Buy) | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Jul 2025 | 79,327 | 0 | - | - | Stock Option (Right to Buy) | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Jul 2025 | 53,433 | 0 | - | - | Stock Option (Right to Buy) | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Jul 2025 | 52,500 | 0 | - | - | Stock Option (Right to Buy) | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 23 Jul 2025 | 37,957 | 0 | - | 0.4 | 13,665 | Common Stock | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Jul 2025 | 35,000 | 0 | - | - | Stock Option (Right to Buy) | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Jul 2025 | 28,800 | 0 | - | - | Stock Option (Right to Buy) | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 May 2025 | 2,643 | 10,859 | - | - | Common Stock | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 May 2025 | 2,343 | 25,782 | - | - | Restricted Stock Unit | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 May 2025 | 784 | 10,075 | - | 0.3 | 235 | Common Stock | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 May 2025 | 300 | 2,100 | - | - | Restricted Stock Unit | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Feb 2025 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Feb 2025 | 9,375 | 28,125 | - | - | Restricted Stock Unit | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Feb 2025 | 9,375 | 10,785 | - | - | Common Stock | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Feb 2025 | 2,780 | 8,005 | - | 0.7 | 1,867 | Common Stock | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Feb 2025 | 300 | 2,400 | - | - | Restricted Stock Unit | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Feb 2025 | 300 | 8,305 | - | - | Common Stock | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Feb 2025 | 89 | 8,216 | - | 0.7 | 60 | Common Stock | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Nov 2024 | 300 | 1,508 | - | - | Common Stock | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Nov 2024 | 300 | 2,700 | - | - | Restricted Stock Unit | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Nov 2024 | 98 | 1,410 | - | 0.5 | 52 | Common Stock | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Aug 2024 | 300 | 1,297 | - | - | Common Stock | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Aug 2024 | 300 | 3,000 | - | - | Restricted Stock Unit | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Aug 2024 | 89 | 1,208 | - | 0.7 | 64 | Common Stock | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 May 2024 | 300 | 3,300 | - | - | Restricted Stock Unit | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 May 2024 | 300 | 1,097 | - | - | Common Stock | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 May 2024 | 100 | 997 | - | 3.7 | 373 | Common Stock | |
Elevation Oncology Inc | Furlong Tammy | CHIEF FINANCIAL OFFICER | 15 Feb 2024 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Feb 2024 | 37,500 | 37,500 | - | - | Restricted Stock Unit | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Feb 2024 | 1,200 | 1,200 | - | - | Common Stock | ||
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 15 Feb 2024 | 1,200 | 3,600 | - | - | Restricted Stock Unit | ||
Elevation Oncology Inc | Furlong Tammy | CHIEF FINANCIAL OFFICER | 15 Feb 2024 | 403 | 797 | - | 2.8 | 1,116 | Common Stock | |
Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | 12 Jul 2023 | 53,433 | 53,433 | - | - | Stock Option (Right to Buy) |